Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. - Wikidata - wikimedia - TriplyDB

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

http://www.wikidata.org/entity/Q36453167

about

The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells Cytokine profiles of cultured microvascular endothelial cells from the human intestine A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)Human Mig chemokine: biochemical and functional characterization The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans Sulodexide and glycosaminoglycans in the progression of renal disease Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1 ) Binding to Heparin Cobra CRISP Functions as an Inflammatory Modulator via a Novel Zn2+- and Heparan Sulfate-dependent Transcriptional Regulation of Endothelial Cell Adhesion Molecules The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8 Versican interacts with chemokines and modulates cellular responses The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity The cell surface receptor G6b, a member of the immunoglobulin superfamily, binds heparin N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3 In silico analysis reveals sequential interactions and protein conformational changes during the binding of chemokine CXCL-8 to its receptor CXCR1 Profiling heparin-chemokine interactions using synthetic tools Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.Activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells.Modulation of Interleukin-12 activity in the presence of heparin GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth Interference with glycosaminoglycan-chemokine interactions with a probe to alter leukocyte recruitment and inflammation in vivo.Structural diversity of heparan sulfate binding domains in chemokines Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium.Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies.Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG.Heparin-protein interactions.Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration.Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis)The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines.Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).Visualization of chemokine binding sites on human brain microvessels Neutrophils cascading their way to inflammation The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells.

P2860

Q24632813-CEF59F0F-6DE0-4660-9758-26EFA51A7729 Q24646849-7BED161B-1347-4C3D-BA8E-47470EF28085 Q24670764-D300BE30-B706-40B7-9B41-3B8E4C95F441 Q24677007-85BE652E-57CB-4938-824F-FE934B2741C1 Q24678720-5D109A10-E963-4FAC-9CE8-EE644D09494B Q24685887-2671F66A-008C-44ED-9F90-8F90BE55260F Q26865592-A6CA073C-1BBC-4829-B277-92E90ACF5E7B Q26991825-687A705F-7039-4BC7-835B-7F7544F69402 Q27323044-295911BB-6544-4553-8D55-013608487951 Q27643703-C8D565DA-86CF-43D2-B384-6328574AE0A3 Q27664872-63AB3744-9D08-45C1-9C3B-B17D100A6024 Q27729945-556B36E7-4E0F-4A9D-AECE-1BC1F0DBF42C Q28116959-A78FE983-74A6-4749-863C-6D7F99693B4C Q28138079-6BF4E185-13C8-4D8C-98B2-6AC59A3E211F Q28140341-B332301D-2E3C-47E5-AA88-EB9278C76ADD Q28246578-F7C4D9B7-674B-44E7-B9F5-1F430DDA7541 Q28272993-2E1FDF73-6E91-4DE2-A787-86B306E1C70C Q28542001-60C2AE4B-4752-46EB-BB9B-A42FF9073F95 Q30838810-9414A03A-FC5F-4FC9-82DA-DAD25EA2CFBD Q30874393-B3E871A7-4973-4DDE-B085-F2D7962B9D6B Q33805045-AB2B672C-B264-4937-8874-247B12DE3FA2 Q33903041-3F4652BF-6324-4B16-A129-097780A63CE0 Q34000565-8FD3A02F-64A4-44BF-9069-271057E36DDE Q34004904-90E62349-350F-46D3-9F88-63F8CE15BE67 Q34008721-1FCDA4A9-75A0-4BDD-8F43-E2259ACE3C2D Q34157586-5EA1E70B-3246-48D4-AA7D-BDF73814E96F Q34308645-ACBEF462-46F6-4C12-9849-36052D630EB6 Q34656904-2C89470F-316E-4D5C-8803-46BB9E5DDC65 Q35030190-14F590B4-3CE4-4E0F-87C2-3C63E32FED6A Q35312128-1DB9E705-5F05-4C4F-92D3-BC297B5ADDAB Q35553784-FAF12F95-1DA3-478E-A043-CFF1D5A1A992 Q35558287-1509CA94-EA10-4717-A36A-C060F55A3B28 Q35662589-C431D26D-894B-43A2-B7A4-32A4DE25A79C Q35886322-4BD16E7F-D02C-48E9-8210-733F3ED8FBC5 Q35945466-4B44BAFE-7A15-4461-9631-7D2CCB3D4850 Q36236005-F4016D28-47E2-445E-919E-C34DD1BE1DD9 Q36256452-3039D670-F01C-4CFF-B3FD-F7D5FD2E36E9 Q36315860-04C4AF5C-D044-45E3-B876-D6923ABC9559 Q36365144-C717FF00-96B6-4418-B086-9D429348E8C7 Q36367585-13B0C650-C34A-4F24-A3FF-A36284A42B63

P2860

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

http://www.wikidata.org/entity/Q36453167

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

@ast

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

@en

type

label

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

@ast

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

@en

prefLabel

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

@ast

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

@en

P1433

Q36453167-D700F0AC-B34E-417D-B721-C2D34623ED46

P1476

Q36453167-F54E6849-86F0-49FC-BF52-F01B2CA9D403

P2093

Q36453167-0D681867-9955-4DC0-BC12-174112D8A0B2

Q36453167-A4D7369A-D8C6-4998-A8B0-E221BF14771E

Q36453167-A881D458-0AFF-46AC-B23F-F734030B28F4

Q36453167-B5B24160-D4C4-4D9A-B7A5-F77D39CA97A5

P2860

Q36453167-1385D163-D480-486D-B9F7-0A4B6C1736EF

Q36453167-16195F23-A5DB-41D5-9AF8-FE46E8F8E6CF

Q36453167-21F3E1E1-E108-4B61-850E-71F7FC4F8C7B

Q36453167-2867427F-A1F7-4A8B-AD3C-A401C55C34DD

Q36453167-31CDDE34-0211-411D-8FBA-23BA9C55DB87

Q36453167-3A092D18-55E9-4F1D-8598-214699CC2346

Q36453167-40AE80CD-CBFA-482C-A3F2-C39B8F850C0F

Q36453167-54FD38FE-8784-44A2-9A6D-16286FDFEDBC

Q36453167-56EA3730-1E53-48B6-AD8D-EE1C63AE9188

Q36453167-5A985614-0A2E-4E78-9633-E0160DFBA504

P304

Q36453167-D80C3575-FD37-48A6-8BD9-9BAD53A1CD95

P31

Q36453167-BC07A491-6BA9-4934-B70C-BBEC2F95EA23

P356

Q36453167-AF95815C-E2D3-467C-A337-B2FA3492B21A

P407

Q36453167-0DEE3E86-5C3A-48FA-8809-787398AA9A48

P433

Q36453167-C06CCBC1-7856-4A5A-A120-A7AC78778E23

P478

Q36453167-D070F935-D39B-428A-98CE-A29632EE9B0F

P50

Q36453167-1506A6C2-F076-4342-955A-BC1C466353D1

P577

Q36453167-5D406627-D65F-407E-A6E9-6A3CD7D14C14

P5875

Q36453167-00198259-56BA-4722-A469-71F7F0D5D770

P698

Q36453167-567310F0-71BE-43DE-9C9C-6F6D2E26C2BF

P932

Q36453167-5979903A-AA32-4FBC-AD46-7159C4E6AB13

P356

PNAS.90.15.7158

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

@en

P2093

Baggiolini M

http://www.w3.org/2001/XMLSchema#string

Clark-Lewis I

http://www.w3.org/2001/XMLSchema#string

Ehrengruber MU

http://www.w3.org/2001/XMLSchema#string

Webb LM

http://www.w3.org/2001/XMLSchema#string

P2860

Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta

Three-dimensional structure of human basic fibroblast growth factor

Crystal structure of interleukin 8: symbiosis of NMR and crystallography

Three-dimensional structure of interleukin 8 in solution

The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution

A new generation of Ca2+ indicators with greatly improved fluorescence properties

Interleukin-8, a chemotactic and inflammatory cytokine

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.

Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.

P304

7158-7162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.90.15.7158

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

1993-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14853531

http://www.w3.org/2001/XMLSchema#string

P698

8346230

http://www.w3.org/2001/XMLSchema#string

P932

47095

http://www.w3.org/2001/XMLSchema#string